Formation of Incision Complex in GG-NER
REACTOME PATHWAYThe Formation of Incision Complex in GG-NER pathway (Reactome ID: R-HSA-5696395) involves 6 genes and is affected by 34 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Formation of Incision Complex in GG-NER
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | — | 150 |
| 2 | Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent | — | 299 |
| 3 | Bortezomib | — | 300 |
| 4 | Camptothecin | — | 300 |
| 5 | Clofarabine | — | 298 |
| 6 | Daunorubicin | — | 298 |
| 7 | Demecolcine | — | 246 |
| 8 | Epirubicin | — | 300 |
| 9 | Gemcitabine | — | 300 |
| 10 | Homoharringtonine Semisynthetic derivative of harringtonine that acts as | — | 300 |
| 11 | Irinotecan | — | 298 |
| 12 | Nocodazole Nocodazole is | — | 215 |
| 13 | Podophyllotoxin | — | 14 |
| 14 | Teniposide | — | 299 |
| 15 | Thapsigargin | — | 300 |
| 16 | Trabectedin | — | 297 |
| 17 | naringin | — | 300 |
| 18 | Chlorhexidine | — | 299 |
| 19 | Perphenazine | — | 297 |
| 20 | Sphingosine | — | 300 |
| 21 | Resveratrol | — | 298 |
| 22 | Sertraline | — | 1,000 |
| 23 | Astemizole Antihistamine drug now withdrawn from | — | 280 |
| 24 | Canrenone | — | 300 |
| 25 | Thioridazine | — | 35 |
| 26 | Cefdinir | — | 298 |
| 27 | Cefixime | — | 300 |
| 28 | Hexachlorophene | — | 300 |
| 29 | Oxytetracycline | — | 300 |
| 30 | hydroxyfasudil [Supplementary Concept] | — | 11 |
| 31 | pictilisib | — | 25 |
| 32 | Sorafenib | — | 300 |
| 33 | ninhydrin | — | 300 |
| 34 | Tripterygium | — | 300 |
About the Formation of Incision Complex in GG-NER Pathway
The Formation of Incision Complex in GG-NER pathway is catalogued in Reactome (ID: R-HSA-5696395) and involves 6 genes. In the BiohacksAI corpus, 34 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CDK7, ERCC3, PARP1, RBX1, SUMO1.